Generic Pharmaceutical Manufacturing, Generic Drugs

Lannett Company Inc

Lannett Company, Inc.

Lannett Company, Inc. founded in 1942, develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms to customers throughout the United States. Lannett markets its products primarily to drug wholesalers, retail drug chains, distributors, and government agencies.

We employ a staff of dedicated people who work together to produce drug products that sick people can afford to buy that will treat their illness, make them well, reduce suffering and improve the quality of their lives.

News & Events

02/07/2012 - Lannett Reports Fiscal 2012 Second Quarter Financial Results

Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2012 second quarter and six months ended December 31, 2011.
Read More

01/31/2012 - Lannett Receives FDA Approval For ANDA Supplement For Phentermine HCL Capsules, 15 MG

Lannett Company, Inc. (NYSE AMEX: LCI), today announced that it has received approval from the U.S Food and Drug Administration (FDA) of its supplemental Abbreviated New Drug Application (ANDA) for Phentermine HCL Capsules, 15 mg.
Read More

01/30/2012 - Lannett To Report Fiscal 2012 Second-Quarter Financial Results And Host Conference Call On Tuesday, February 7

Lannett Company, Inc. (NYSE AMEX: LCI), a manufacture of generic pharmaceuticals, today announced that the company will release its fiscal 2012 second-quarter financial results on Tuesday, February 7, 2012 after the market closes.
Read More
Listen To Audio Webcast

01/30/2012 - Lannett Receives FDA Approval For Hydrochlorothiazide Capsules, 12.5 MG

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide Capsules, 12.5 mg.
Read More

01/04/2012 - Lannett Reaches Special Protocol Assessment Agreement With FDA For Cocaine HCL Phase III Trial

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA), regarding the design of a Phase III study of the companys Cocaine HCl topical solution product, C-Topical.
Read More

Authorized Distributors of Record

Lannett Company Inc is the Authorized Distributors of Record for many products.
Download the full list.

Community Relations

Our dedicated employees strive to position Lannett as an industry leader that is focused on quality and integrity, as well as giving back to the community we serve. Lannett has a history of supporting schools, hospitals, veterans and their families, institutions, rehabilitation centers, cancer research, as well as the local fire and police departments. Read More.

Verified-Accredited Wholesale Distributors

Wholesale distributors that display the VAWD Seal as part of their accreditation have undergone a criteria compliance review, including a rigorous review of their operating policies and procedures, licensure verification, survey of facility and operations, background checks, and screening through the NABP Clearinghouse. Accredited facilities are reviewed annually and undergo a site survey every three years.

Made in America